Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

COTTONE, Mario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.710
EU - Europa 4.198
AS - Asia 3.041
SA - Sud America 522
AF - Africa 112
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 5
Totale 17.611
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.529
SG - Singapore 1.169
CN - Cina 1.016
IT - Italia 941
UA - Ucraina 770
DE - Germania 453
FI - Finlandia 450
BR - Brasile 434
GB - Regno Unito 344
RU - Federazione Russa 338
HK - Hong Kong 287
IE - Irlanda 279
PL - Polonia 177
VN - Vietnam 139
CA - Canada 121
SE - Svezia 115
IN - India 114
FR - Francia 102
BE - Belgio 43
KR - Corea 43
MX - Messico 39
CI - Costa d'Avorio 37
ES - Italia 35
NL - Olanda 35
TR - Turchia 33
RO - Romania 30
AR - Argentina 29
JP - Giappone 29
ZA - Sudafrica 27
MY - Malesia 26
BD - Bangladesh 24
IQ - Iraq 24
PK - Pakistan 24
AU - Australia 22
UZ - Uzbekistan 18
VE - Venezuela 18
CH - Svizzera 17
AT - Austria 14
EC - Ecuador 14
AE - Emirati Arabi Uniti 13
EG - Egitto 13
SA - Arabia Saudita 11
MA - Marocco 10
ID - Indonesia 9
PH - Filippine 9
PY - Paraguay 9
RS - Serbia 9
GR - Grecia 8
LB - Libano 8
LT - Lituania 8
KE - Kenya 7
BG - Bulgaria 6
CO - Colombia 6
IR - Iran 6
TW - Taiwan 6
IL - Israele 5
PA - Panama 5
PT - Portogallo 5
AL - Albania 4
CL - Cile 4
DZ - Algeria 4
EU - Europa 4
JM - Giamaica 4
NG - Nigeria 4
NP - Nepal 4
BO - Bolivia 3
BY - Bielorussia 3
GE - Georgia 3
JO - Giordania 3
KG - Kirghizistan 3
NO - Norvegia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AM - Armenia 2
AZ - Azerbaigian 2
BB - Barbados 2
BW - Botswana 2
CM - Camerun 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
HU - Ungheria 2
LK - Sri Lanka 2
PE - Perù 2
PS - Palestinian Territory 2
TN - Tunisia 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MM - Myanmar 1
Totale 17.603
Salva come PNG Salva come JPEG
Città #
Fairfield 1.141
Ashburn 1.066
Woodbridge 876
Singapore 719
Chandler 657
Houston 630
Wilmington 469
Jacksonville 439
Ann Arbor 438
Seattle 423
Cambridge 387
Dublin 278
Hong Kong 278
Palermo 215
Medford 210
Beijing 175
Nanjing 160
Los Angeles 139
Princeton 139
Zgierz 137
Altamura 126
Moscow 126
Tulsa 109
Dearborn 91
Lawrence 89
Des Moines 82
Boardman 79
San Diego 72
Hefei 71
Munich 71
Dallas 67
Montréal 61
New York 60
Mcallen 58
Santa Clara 56
Buffalo 52
Shenyang 52
Ho Chi Minh City 49
Milan 46
Nanchang 46
Venice 42
Brussels 41
Kumar 41
London 40
Ludwigshafen am Rhein 38
Abidjan 37
Seongnam 37
Tianjin 37
The Dalles 36
Hanoi 34
Jiaxing 34
Omaha 34
Redwood City 30
Frankfurt am Main 29
Phoenix 29
São Paulo 29
Hebei 28
Changsha 27
Council Bluffs 27
Chicago 26
Saint Petersburg 26
Tokyo 24
Jinan 23
Auburn Hills 22
Guangzhou 21
San Paolo di Civitate 21
Rome 20
Warsaw 19
Atlanta 18
Verona 18
Montreal 17
Columbus 16
Johannesburg 16
San Mateo 16
Shanghai 16
Brooklyn 15
Chennai 15
Washington 15
Nuremberg 14
Zhengzhou 14
Kuala Lumpur 13
Orange 13
Rio de Janeiro 13
Falls Church 12
Lanzhou 12
Pune 12
San Francisco 12
Tashkent 12
Brasília 11
Poplar 11
Amsterdam 10
Denver 10
Orem 10
Bremen 9
Curitiba 9
Den Haag 9
Indiana 9
Izmir 9
Mexico City 9
Petaling Jaya 9
Totale 11.695
Salva come PNG Salva come JPEG
Nome #
NUTRITION, MALNUTRITION AND DIETARY INTERVENTIONS IN INFLAMMATORY BOWEL DISEASE 515
Prurigo nodularis of Hyde treated with low-dose thalidomide. 318
Physicians' Knowledge and Application of Immunization Strategies in Patients with Inflammatory Bowel Disease: A Survey of the Italian Group for the Study of Inflammatory Bowel Disease 203
Incidence of Crohn's disease and Card 15 mutation in a small township in Sicily 200
An open-safety study of dual antiviral therapy in real-world patients with chronic hepatitis C 197
Budesonide MMX and mesalamine to induce remission in patients with ulcerative colitis 196
Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease 194
Severe acute colitis associated with CMV:a prevalence study 188
Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis 187
Postoperative maintenance therapy for inflammatory bowel disease 183
An Unusual Presentation of Zollinger-Ellison Syndrome 182
A. Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease. 182
Cyclosporine or infliximab as rescue therapy in severe 2 refractory ulcerative colitis: Early and long-term data 3 from a retrospective observational study 180
Frequency of NOD2/CARD15 variants in both sporadic and familial cases of Crohn's disease across Italy. An Italian Group for Inflammatory Bowel Disease study 177
Infliximab and ulcerative colitis 174
Heart failure and anti tumor necrosis factor-alpha in systemic chronic inflammatory diseases 174
Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in post-operative Crohn's disease 173
Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease. 172
Beclomethasone dipropionate in Crohn's ileitis: A randomised, double-blind trial. 168
JC Virus, Helicobacter pylori, and Oesophageal Achalasia: Preliminary Results from a Retrospective Case-Control Study 167
Efficacy and safety of endoscopic balloon dilation of symptomatic intestinal Crohn's disease strictures. 165
Clinical and endoscopic presentation of primary gastric lymphoma:a multicenter study 164
EFFICACY AND SAFETY OF ENDOSCOPIC BALLOON DILATION OF SYMPTOMATIC INTESTINAL CROHN'S DISEASE STRICTURES 162
The frame.shift mutation of the NOD2/Card15 gene is significantly increased in ulcerative colitis: an IG-IBD study 161
Complete clinical remission after high dose immune suppression and autologous hematopoietic stem cell transplantation in severe Crohn's disease refractory to immunosuppressive and immunomodulator therapy 161
Oral lichen planus after certolizumab pegol treatment in a patient with Crohn's disease 161
An unusual presentation of T-lymphoma in a Crohn's 4 disease patient treated with combo therapy: We are 5 willing to take a risk of serious adverse events for a 6 doubtful benefit? 161
Toxic megacolon and human Cytomegalovirus in a series of severe ulcerative colitis patients 161
A Propensity Score-matched Comparison of Infliximab and Adalimumab in Tumour Necrosis Factor-α Inhibitor-naïve and Non-naïve Patients with Crohn's Disease: Real-Life Data from the Sicilian Network for Inflammatory Bowel Disease 161
The role of portal vein thrombosis in the clinical course of inflammatory bowel diseases: report on three cases and review of the literature. 160
Six year adalimumab efficacy in steroid-dependent Crohn's disease patients: A prospective single-center real life study 159
Clinical course of ulcerative colitis 158
A rare case of ulcerative proctitis associated with type B lymphomatoid papulosis and superimposed human cytomegalovirus infection. 158
Leucocytapheresis in patients with moderate severe steroid dependant Ulcerative Colitis:clinical response without endoscopic response 155
Systematic review: macrophage activation syndrome in inflammatory bowel disease 154
Methodological problems in RCTs on IBD 151
Meta-analysis: remission and response from control arms of randomized trials of biological therapies for active luminal Crohn's disease. 149
Crohn's disease:a comparative prospective study of transabdominal ultrasonography,small intestine contrastultrasonography and small bowel enema 148
Cytomegalovirus disappearance after treatment for refractory ulcerative colitis in 2 patients treated with infliximab and 1 patient with leukapheresis 148
MINIMIZING INFLIXIMAB TOXICITY IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE 147
Cancer in Crohn's Disease patients treated with infliximab: A long-term multicenter matched pair study 147
IL-23R determines susceptibility in Crohn's disease in a Mediterranean area 147
COULD JC VIRUS PROVOKE METASTASIS IN COLON CANCER? 146
Improving patients Qol:how the success of treatment can improve workability 141
Antibiotic treatment of Crohn's disease:results of a multicentre double blind randomized placebo controlled trial with Rifamixin 141
Tofacitinib in active ulcerative colitis 141
Infliximab in the treatment of Crohn's disease :predictors of response in an Italian multicenter open study 139
Infliximab, azathioprine or combination therapy in the treatment of active Crohn's disease. 139
Methodology for high-quality studies on course and prognosis of inflammatory bowel disease. 139
CLINICAL COURSE OF SEVERE COLITIS: A COMPARISON BETWEEN CROHN'S DISEASE AND ULCERATIVE COLITIS. 137
Calprotectin in the prediction of endoscopic post-surgical recurrence in CD 136
COLORECTAL CANCER IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: PRELIMINARY RESULTS FROM AN ONGOING CASE-CONTROL STUDY 136
A real life comparison of the efficacy of adalimumab versus golimumab in moderate-to-severe ulcerative colitis. A multicenter experience from the sicilian network for inflammatory bowel disease (SN-IBD) 136
Unusual perforation after balloon dilation in a Crohn's disease patient:report of a case 135
Cancer in Infliximab-treated or untreated crohn's disease patients:a 2 years longer follow-up from a multicenter matched pair study 134
Probiotics, prebiotics and symbiotics in inflammatory bowel diseases: state-of-the-art and new insights 133
Radiologia e malattia celiaca dell'adulto 128
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. 128
Long term follow-up in an incident cohort of 583 pts with CD 127
Over-expression of paneth cell-derived anti-microbial peptides in the gut of patients with ankylosing spondylitis and subclinical intestinal inflammation. 127
The role of calprotectin in predicting endoscopic post-surgical recurrence in asymptomatic Crohn's disease: a comparison with ultrasound 126
THE ROLE OF CARD15 MUTATIONS AND SMOKING IN THE COURSE OF DISEASE IN A MEDITERRANEAN AREA 126
Oral valganciclovir for coloni c dilatation in ulcerative colitis associated with Human cytomegalovirus infection 126
A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analysis. 126
Infliximab in moderate to severe sateroid dipendent or refractory severe ulcerative colitis:short term results of 21 case treated 124
CA-19 to rule out Pancreatic or Biliary Cancer among patients with cholestasis:an unsuitable ? 124
Infliximab prevents Crohn's disease recurrence after ileal resection. 123
ATG16L1 contribution to Crohn's disease risk in Sicily 123
Is 5-ASA Still the Treatment of Choice for Ulcerative Colitis? 123
Infliximab to treat Crohn's disease: an update 123
Burden of Crohn's disease: economics and quality of life aspects in Italy. 122
Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients refractory or intolerant to infliximab: a real-life multicenter experience of compassionate use. 121
Adalimumab in steroid-dependent Crohn's disease patients: Prognostic factors for clinical benefit 120
Investigational agents for Crohn's disease. 119
Radiofrequency thermal ablation vs percutaneous ethanol injection for small hcc in cirrhosis:metanalysis of randomized controlled trials 119
Intestinal permeability and Genetic determinants in patients,first degree relatives,and controls in a High incidence area's of Crohn's disease in Southern Italy 116
Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology. 116
VALIDATION OF A MODIFIED MODEL OF TNBS-INDUCED COLITIS IN RATS. HOW TO INDUCE A CHEMICAL COLITIS IN RATS. 116
The role of NOD2/CARD15 mutation and smoking in the course of Crohn's disease in a Mediterranean area 115
Early postoperative recurrence of severe crohn's disease, with colonic involvement and associated human cytomegalovirus infection, treated with oral valganciclovir and adalimumab. 113
Infliximab in the treatment of steroid resistant dependant and fistulating crohn's disease:an analysis of predictors of response in an italian multicenter open study in 573 pts 112
Cytomegalovirus and Inflammmatory bowel disease:is there a link ? 112
Marked impact of IL28B genotype in the natural clearance of hepatitis C virus in patients with haemoglobinopathies. 112
The sicilian network for inflammatory bowel disease (SN-IBD): preliminary data on efficacy of biological therapy. 112
Psychopharmacology treatment and psychological interventions in irritable bowel syndromel 111
Smoking therapy may be an extreme cure in exsmokers with steroid-dependent and resistant ulcerative colitis. 111
Ultrasound in Crohn's disease 110
efficacy and safety of endoscopic ballon dilatation of symptomatic gastrointestinal Crohn's disease strictures 110
Natural history of Cytomegalovirus infection diagnosed with moderate-severe ulcerative colitis 110
NEWLY DIAGNOSED NEOPLASIA IN CROHN DISESE PATIENTS TREATED WITH INFLIXIMAB;A 1 YEAR LONGER FOLLOW UP FROM A MULTICENTER MATCHED PAIR STUDY 109
PREVALENCE OF CARD15/NOD2 MUTATIONS IN SICILIAN POPULATION 108
Appropriateness of immunosupprerssive drugs in inflammatory bowel disease assessed by RAND method :Italian group for IBD position statement 108
Le malattie infiammatorie dell'intestino 107
Severe cutaneous psoriasis after certolizumab pegol treatment;report of a case. 107
Natural history of cytomegalovirus infection in a cohort of patients diagnosed with moderate severe ulcerative colitis 105
Occul Hepatitis B and infliximab induced HBV reactivation 105
Placebo Therapy in Crohn's disease 105
Is splenectomy a treatment option for aseptic abscesses in patients with Crohn's disease? 105
Salycilate in the prevention of post-surgical recurrence in Crohn's disease 104
a meta-analysis of the placebo rate of clinical relapse and severe endoscopic recurrence in post-operative maintenance therapy in Crohn's disease 104
Totale 14.599
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.149
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.149
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.137 0 0 0 0 0 63 170 102 246 179 171 206
2021/20221.472 62 376 21 51 43 54 85 67 162 199 84 268
2022/20231.900 202 365 35 185 242 260 71 172 245 12 91 20
2023/2024781 46 145 39 53 91 150 75 34 2 54 32 60
2024/20252.017 49 101 101 230 88 77 109 147 148 216 252 499
2025/20262.857 416 228 421 589 736 467 0 0 0 0 0 0
Totale 17.902